News
Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…
Read More about First gene therapy for a blinding eye disease receives FDA approval
In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia,…
Read More about Survival of the Fittest: Sustaining Cells Through Transplantation
In medicine, innovative treatments don’t emerge out of thin air. They are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye…
Read More about Understanding the Retina: AMD and Exploratory Science
Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field…
Read More about The Value of iPSCs for Stem Cell Therapy
Dr. Brian Ballios has restored vision in mice, but he is not stopping there. He is on a mission to develop stem cell therapies for people living with blindness and has a…
Read More about Clinician-Scientist Emerging Leader Award: Dr. Brian Ballios
Artificial intelligence is in the news more frequently than ever, but it’s not typically associated with vision research. That may not be the case for long: incredible progress is being made in…
Read More about Could Artificial Intelligence Revolutionize the Treatment of Eye Diseases?Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
